n-succinimidyl 3-(2-pyridyldithio)propionate has been researched along with Disease Models, Animal in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Boehm, DA; Flavell, DJ; Flavell, SU; Kohler, JA; Okayama, K | 1 |
1 other study(ies) available for n-succinimidyl 3-(2-pyridyldithio)propionate and Disease Models, Animal
Article | Year |
---|---|
Therapy of human T-cell acute lymphoblastic leukaemia in severe combined immunodeficient mice with two different anti-CD7-saporin immunotoxins containing hindered or non-hindered disulphide cross-linkers.
Topics: Animals; Antibodies; Antigens, CD; Antigens, CD7; Antigens, Differentiation, T-Lymphocyte; Antineoplastic Agents, Phytogenic; Child, Preschool; Cross-Linking Reagents; Disease Models, Animal; Disulfides; Dose-Response Relationship, Drug; Electrophoresis, Polyacrylamide Gel; Female; Humans; Immunotoxins; Leukemia-Lymphoma, Adult T-Cell; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Inbred ICR; Mice, SCID; N-Glycosyl Hydrolases; Neoplasm Proteins; Neoplasm Transplantation; Plant Proteins; Ribosome Inactivating Proteins, Type 1; Saporins; Structure-Activity Relationship; Succinimides; Tumor Cells, Cultured | 1994 |